The EBI (European Bioinformatics Institute) based in Cambridge, England, is getting £45m to expand its operations, in particular the Centre's data storage facility. This will be delivered via UKRI's Strategic Priorities Fund. The organization is based in Hinxton, South Cambridgeshire, at the Wellcome Genome Campus, for 25 years, which also hosts the Wellcome Sanger Institute.
Showing posts with label biotech. Show all posts
Showing posts with label biotech. Show all posts
Sunday, 17 March 2019
Monday, 25 February 2019
GE Sells Biotech Business for $21bn to Danaher
The unit sold was part of GE's healthcare business and was slated for its own IPO later in the year. GE shares were 8% up in early trading.
The deal was positively received by analysts covering both companies.
Gabelli commented that it addresses the deleveraging challenges of GE, allowing it to focus on turning around the power business.
Others described it as "significant down payment" on $30bn of expected cash proceeds highlighted on 4Q. Janney's pointed to an uptick in DHR's organic growth rate going forward from 4% to 6%.
Danaher publishes a sustainability report yearly - the latest is on their website.
The deal was positively received by analysts covering both companies.
Gabelli commented that it addresses the deleveraging challenges of GE, allowing it to focus on turning around the power business.
Others described it as "significant down payment" on $30bn of expected cash proceeds highlighted on 4Q. Janney's pointed to an uptick in DHR's organic growth rate going forward from 4% to 6%.
Danaher publishes a sustainability report yearly - the latest is on their website.
Subscribe to:
Posts (Atom)